Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trialHugo Ford, Janet Dunn, Srinivasan Madhusudan et al.|The Lancet Oncology|2013Cited by 604
A guideline on the molecular ecosystem regulating ferroptosisEnyong Dai, Daolin Tang, Xin Chen et al.|Nature Cell Biology|2024Cited by 251
Ketogenic diet promotes tumor ferroptosis but induces relative corticosterone deficiency that accelerates cachexiaMiriam Ferrer, Tobias Janowitz|Cell Metabolism|2023Cited by 100
Opportunities and challenges for innovative and equitable healthcareDavid J. Ecker, Michael R. Hayden, Clarice D. Aiello et al.|Nature Reviews Drug Discovery|2024Cited by 8